Literature DB >> 6118865

Specific receptor for the opioid peptide dynorphin: structure--activity relationships.

C Chavkin, A Goldstein.   

Abstract

The structural features responsible for the high potency and opiate receptor specificity of the opioid peptide dynorphin in the guinea pig ileum myenteric plexus were examined. Successive removal of COOH-terminal amino acids from dynorphin-(1--13) demonstrated important contributions of lysine-13, lysine-11, and arginine-7 to the potency. Removal of the NH2-terminal tyrosine abolished the biologic activity. Several other structural modifications were shown to affect potency: substitution of D-alanine for glycine-2 reduced the potencies of dynorphin-(1--13) amide, -(1--11), and -(1--10); and methyl esterification of the COOH terminus enhanced the potencies of dynorphin-(1--12), -(1--10), -(1--9), -(1--8), and -(1--7). Within the dynorphin sequence, lysine-11 and arginine-7 were found to be important for selectivity of interaction with the dynorphin receptor, which is distinguishable from the mu receptor in this tissue.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6118865      PMCID: PMC349077          DOI: 10.1073/pnas.78.10.6543

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  A synthetic peptide with morphine-like pharmacologic action.

Authors:  A Goldstein; J S Goldstein; B M Cox
Journal:  Life Sci       Date:  1975-12-01       Impact factor: 5.037

2.  Structure-activity relationships of methionine-enkephalin.

Authors:  B A Morgan; C F Smith; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  J Pharm Pharmacol       Date:  1976-08       Impact factor: 3.765

3.  ACTH: a short introductory review.

Authors:  R Schwyzer
Journal:  Ann N Y Acad Sci       Date:  1977-10-28       Impact factor: 5.691

4.  alpha-Neo-endorphin : a "big" Leu-enkephalin with potent opiate activity from porcine hypothalami.

Authors:  K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1979-01-15       Impact factor: 3.575

5.  Opiate activity and receptor selectivity of dynorphin1-13 and related peptides.

Authors:  M Wüster; R Schulz; A Herz
Journal:  Neurosci Lett       Date:  1980-10-20       Impact factor: 3.046

6.  (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic.

Authors:  C B Pert; A Pert; J K Chang; B T Fong
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

7.  Biosynthesis of bacterial glycogen. Isolation and characterization of the pyridoxal-P allosteric activator site and the ADP-glucose-protected pyridoxal-P binding site of Escherichia coli B ADP-glucose synthase.

Authors:  T F Parsons; J Preiss
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

8.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

9.  Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs.

Authors:  N Ling; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

10.  Morphine-tolerant longitudinal muscle strip from guinea-pig ileum.

Authors:  A Goldstein; R Schulz
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

View more
  89 in total

Review 1.  Dynorphin A analogs for the treatment of chronic neuropathic pain.

Authors:  Sara M Hall; Yeon Sun Lee; Victor J Hruby
Journal:  Future Med Chem       Date:  2016-01-29       Impact factor: 3.808

2.  Photoactivatable neuropeptides for spatiotemporally precise delivery of opioids in neural tissue.

Authors:  Matthew R Banghart; Bernardo L Sabatini
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

Review 3.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

4.  Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalin.

Authors:  D M Dixon; J R Traynor
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

5.  Evidence for the modulation of nociception in mice by central mast cells.

Authors:  C L Kissel; K J Kovács; A A Larson
Journal:  Eur J Pain       Date:  2017-07-19       Impact factor: 3.931

Review 6.  Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors.

Authors:  Alan R Gintzler; Nai-Jiang Liu
Journal:  Front Neuroendocrinol       Date:  2012-10-02       Impact factor: 8.606

7.  Effect of prodynorphin-derived opioid peptides on the ovulatory luteinizing hormone surge in the proestrous rat.

Authors:  Qiang Zhang; Robert V Gallo
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

8.  The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior.

Authors:  Jane V Aldrich; Sanjeewa N Senadheera; Nicolette C Ross; Michelle L Ganno; Shainnel O Eans; Jay P McLaughlin
Journal:  J Nat Prod       Date:  2013-01-17       Impact factor: 4.050

9.  Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.

Authors:  G T Shearman; R Schulz; P W Schiller; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Solid Phase Synthesis and Application of Labeled Peptide Derivatives: Probes of Receptor-Opioid Peptide Interactions.

Authors:  Jane V Aldrich; Vivek Kumar; Bhaswati Dattachowdhury; Angela M Peck; Xin Wang; Thomas F Murray
Journal:  Int J Pept Res Ther       Date:  2008-12-01       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.